Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Primary Myelofibrosis × luspatercept × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Primary Myelofibrosis 1 Hematologic Neoplasms 1

Interventions

luspatercept 1 fludarabine phosphate 1 eltrombopag 1 Whole-Body Irradiation 1 Thiotepa 1 Melphalan 1 Etoposide 1 Cyclophosphamide 1 Carboplatin 1 Busulfan 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07539779 2026-04-20

Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting

MyeloidOther hematologic neoplasm

Hematologic Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡